Skip to main content
. 2023 Apr 20;12(5):1128–1144. doi: 10.21037/tcr-22-2459

Table 4. Survival analysis of different metastatic organs and treatment modalities.

Parameter Non-surgery (months), median (95% CI) Surgery (months), median (95% CI) Log Rank P value
Only lung metastasis 5.00 (4.90–5.11) 15.00 (14.56–15.44) 3,834.12 <0.001
Lung + liver metastasis 2.00 (1.91–2.09) 10.00 (9.46–10.55) 1,548.96 <0.001
Lung + bone metastasis 4.00 (3.86–4.14) 10.00 (9.26–10.74) 442.61 <0.001
Lung + brain metastasis 3.00 (2.82–3.18) 8.00 (6.98–9.02) 125.80 <0.001
Chemotherapy
   Yes 9.00 (8.87–9.13) 24.00 (23.29–24.71) 7,849.03 <0.001
   No 1.00 (0.97–1.03) 9.00 (8.37–9.63)
Radiotherapy
   Yes 6.00 (5.87–6.13) 20.00 (18.71–21.29) 8,923.70 <0.001
   No 3.00 (2.94–3.06) 18.00 (17.39–18.61)

CI, confidence interval.